Platelet reactivity in sepsis syndrome: results from the PRESS study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 36, Issue 12, 2017, Pages 2503-2512

  Akinosoglou, Karolina ^a   Theodoraki, Spyridoula ^a   Xanthopoulou, Ioanna ^a   Perperis, Angelos ^a   Gkavogianni, Theologia ^b   Pistiki, Aikaterini ^b   Giamarellos Bourboulis, Evangelos ^b   Gogos, Charalambos A ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Organ dysfunction; P2Y12 platelet receptor; Platelet reactivity; Platelets; qSOFA; Sepsis

Indexed keywords

BIOLOGICAL MARKER; PURINERGIC P2Y12 RECEPTOR; AUTACOID; CYTOKINE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; INFECTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PLATELET REACTIVITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; VERY ELDERLY; BLOOD; BLOOD CLOTTING PARAMETERS; CASE CONTROL STUDY; METABOLISM; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX; SYNDROME; THROMBOCYTE; THROMBOCYTE ACTIVATION;

BIOMARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; ROC CURVE; SEPSIS; SEVERITY OF ILLNESS INDEX; SYNDROME;

EID: 85028350687     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-017-3093-6     Document Type: Article

References (42)

1. Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, Jaton K, Giulieri S, Delaloye J, Opal S, Tracey K, van der Poll T, Pelfrene E (2015) Sepsis: a roadmap for future research. Lancet Infect Dis 15(5):581–614
2. Gogos CA, Drosou E, Bassaris HP, Skoutelis A (2000) Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181(1):176–180
3. Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13(12):862–874
4. Novosad S, Sapiano M, Grigg C, LakeJ, Robyn M, Dumyati G, Felsen C, Blog D, Dufort E, Zansky S, Wiedeman K, Avery l, Dantes R, Jernigan J, Magill S, Fiore A, Epstein L (2016) Vital Signs: Epidemiology of Sepsis: Prevalence of Health Care Factors and Opportunities for Prevention. MMWR Morb Mortal Wkly Rep 65(33):864–869
5. Thomas MR, Storey RF (2015) The role of platelets in inflammation. Thromb Haemost 114(3):449–458
6. Akinosoglou K, Alexopoulos D (2014) Use of antiplatelet agents in sepsis: a glimpse into the future. Thromb Res 133(2):131–138
7. Liverani E, Rico MC, Tsygankov AY, Kilpatrick LE, Kunapuli SP (2016) P2Y12 receptor modulates sepsis-induced inflammation. Arterioscler Thromb Vasc Biol 36(5):961–971
8. Liverani E, Rico MC, Yaratha L, Tsygankov AY, Kilpatrick LE, Kunapuli SP (2014) LPS-induced systemic inflammation is more severe in P2Y12 null mice. J Leukoc Biol 95(2):313–323
9. Evangelista V, dell’Elba G, Martelli N, Amore C, Pecce R,Piccoli A, Manarini S, Totani L (2007) Anti-inflammatory effects of clopidogrel in the mouse. J Thromb Haemost 5 (Suppl 2):P-M-283
10. Winning J, Baranyai J, Claus R, Eisenhut I, Hamacher J, Reinhart K, Bauer M, Lösche W (2007) Beneficial effects of antiplatelet drugs in patients with community-acquired pneumonia and in endotoxin shock in mice. Crit Care 11(Suppl 2):P27
11. Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, Ecob R, Judge HM, Khan H, West LE, Dockrell DH, Sabroe I, Storey RF (2015) Platelet P2Y12 inhibitors reduce systemic inflammation and its Prothrombotic effects in an experimental human model. Arterioscler Thromb Vasc Biol 35(12):2562–2570
12. Storey RF, James SK, Siegbahn A, Varenhorst C, Held C, Ycas J, Husted SE, Cannon CP, Becker RC, Steg PG, Asenblad N, Wallentin L (2014) Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study. Platelets 25(7):517–525
13. Schoergenhofer C, Schwameis M, Hobl EL, Ay C, Key NS, Derhaschnig U, Jilma B, Spiel AO (2016) Potent irreversible P2Y12 inhibition does not reduce LPS-induced coagulation activation in a randomized, double-blind, placebo-controlled trial. Clin Sci 130(6):433–440
14. von Beckerath N, Pogatsa-Murray G, Wieczorek A, Sibbing D, Schomig A, Kastrati A (2006) Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness. Thromb Haemost 95(5):910–911
15. Boldt J, Menges T, Wollbruck M, Sonneborn S, Hempelmann G (1994) Platelet function in critically ill patients. Chest 106(3):899–903
16. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ (1997) Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 23(4):379–385
17. Johansson D, Shannon O, Rasmussen M (2011) Platelet and neutrophil responses to gram positive pathogens in patients with bacteremic infection. PLoS One 6(11):e26928
18. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31(4):1250–1256
19. Akinosoglou K, Perperis A, Theodoraki S, Alexopoulos D, Gogos C (2017) Sepsis favors high-on-clopidogrel platelet reactivity. Platelets 21:1–3
20. Corrales-Medina VF, Suh KN, Rose G, Chirinos JA, Doucette S, Cameron DW, Fergusson DA (2011) Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med 8(6):e1001048
21. Dalager-Pedersen M, Sogaard M, Schonheyder HC, Nielsen H, Thomsen RW (2014) Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study. Circulation 129(13):1387–1396
22. Leytin V, Shakoor S, Mody M, Allen D, Garvey B, Freedman J (2002) Sepsis- and endotoxemia-generated cytokines do not trigger activation of human platelets. Crit Care Med 30(12):2771–2773
23. Davies GR, Mills GM, Lawrence M, Battle C, Morris K, Hawkins K, Williams PR, Davidson S, Thomas D, Evans PA (2014) The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness. PLoS One 9(9):e108589
24. Sjovall F, Morota S, Asander Frostner E, Hansson MJ, Elmer E (2014) Cytokine and nitric oxide levels in patients with sepsis--temporal evolvement and relation to platelet mitochondrial respiratory function. PLoS One 9(5):e97673
25. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S (2000) Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 28(2):451–457
26. Alt E, Amann-Vesti BR, Madl C, Funk G, Koppensteiner R (2004) Platelet aggregation and blood rheology in severe sepsis/septic shock: relation to the sepsis-related organ failure assessment (SOFA) score. Clin Hemorheol Microcirc 30(2):107–115
27. Yaguchi A, Pradier O, Lobo F et al (2001) Platelet aggregation is impaired at the level of cyclooxygenase and thromboxane synthetase in severe sepsis. Intensive Care Med 27:S166
28. Woth G, Varga A, Ghosh S, Krupp M, Kiss T, Bogar L, Muhl D (2011) Platelet aggregation in severe sepsis. J Thromb Thrombolysis 31(1):6–12
29. Adamzik M, Gorlinger K, Peters J, Hartmann M (2012) Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis. Crit Care 16(5):R204
30. Brenner T, Schmidt K, Delang M, Mehrabi A, Bruckner T, Lichtenstern C, Martin E, Weigand MA, Hofer S (2012) Viscoelastic and aggregometric point-of-care testing in patients with septic shock—cross-links between inflammation and haemostasis. Acta Anaesthesiol Scand 56(10):1277–1290
31. Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ, Werdan K (1995) Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Investig 25(11):843–851
32. Kirschenbaum LA, Aziz M, Astiz ME, Saha DC, Rackow EC (2000) Influence of rheologic changes and platelet-neutrophil interactions on cell filtration in sepsis. Am J Respir Crit Care Med 161(5):1602–1607
33. Vincent JL, Yagushi A, Pradier O (2002) Platelet function in sepsis. Crit Care Med 30(5 Suppl):S313–S317
34. Mangalpally KK, Siqueiros-Garcia A, Vaduganathan M, Dong JF, Kleiman NS, Guthikonda S (2010) Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. J Thromb Thrombolysis 30(3):251–262
35. Kumar V, Sharma A (2009) Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur J Pharmacol 616(1–3):7–15
36. Gaddnas F, Koskela M, Koivukangas V, Risteli J, Oikarinen A, Laurila J, Saarnio J, Ala-Kokko T (2009) Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients. Crit Care 13(2):R53
37. Baurand A, Eckly A, Bari N, Leon C, Hechler B, Cazenave JP, Gachet C (2000) Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost 84(3):484–491
38. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):801–810
39. Williams JM, Greenslade JH, McKenzie JV, Chu K, Brown AF, Lipman J (2017) Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection. Chest 151(3):586–596
40. Dofferhoff A, Buys J (1995) Effects of antibiotics on cytokine release. In: Vincent J (ed) Yearbook of intensive care and emergency medicine. Springer-Verlag, Berlin, pp 465-472
41. Gachet C (2012) P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells. Purinergic Signal 8(3):609–619
42. Matera C, Falzarano C, Berrino L, Rossi F (1992) Effects of tetanus toxin, salmonella typhimurium porin, and bacterial lipopolysaccharide on platelet aggregation. J Med 23(5):327–338